» Articles » PMID: 37107175

Oxidative Stress and Epigenetics: MiRNA Involvement in Rare Autoimmune Diseases

Overview
Date 2023 Apr 28
PMID 37107175
Authors
Affiliations
Soon will be listed here.
Abstract

Autoimmune diseases (ADs) such as Sjögren's syndrome, Kawasaki disease, and systemic sclerosis are characterized by chronic inflammation, oxidative stress, and autoantibodies, which cause joint tissue damage, vascular injury, fibrosis, and debilitation. Epigenetics participate in immune cell proliferation and differentiation, which regulates the development and function of the immune system, and ultimately interacts with other tissues. Indeed, overlapping of certain clinical features between ADs indicate that numerous immunologic-related mechanisms may directly participate in the onset and progression of these diseases. Despite the increasing number of studies that have attempted to elucidate the relationship between miRNAs and oxidative stress, autoimmune disorders and oxidative stress, and inflammation and miRNAs, an overall picture of the complex regulation of these three actors in the pathogenesis of ADs has yet to be formed. This review aims to shed light from a critical perspective on the key AD-related mechanisms by explaining the intricate regulatory ROS/miRNA/inflammation axis and the phenotypic features of these rare autoimmune diseases. The inflamma-miRs miR-155 and miR-146, and the redox-sensitive miR miR-223 have relevant roles in the inflammatory response and antioxidant system regulation of these diseases. ADs are characterized by clinical heterogeneity, which impedes early diagnosis and effective personalized treatment. Redox-sensitive miRNAs and inflamma-miRs can help improve personalized medicine in these complex and heterogeneous diseases.

Citing Articles

Assessment of relationships between epigenetic age acceleration and multiple sclerosis: a bidirectional mendelian randomization study.

Liu H, Zhang H, Yin Z, Hou M Epigenetics Chromatin. 2025; 18(1):7.

PMID: 39885544 PMC: 11780769. DOI: 10.1186/s13072-025-00567-9.


Efficacy of RCI001 as a Therapeutic Candidate in a Primary Sjögren Syndrome Mouse Model.

Kang H, Jung Y, Moon J, Ryu J, Yoon C, Kim Y Cornea. 2024; 44(2):226-233.

PMID: 39288434 PMC: 11676593. DOI: 10.1097/ICO.0000000000003696.


Exosome-derived microRNAs: emerging players in vitiligo.

Li W, Pang Y, He Q, Song Z, Xie X, Zeng J Front Immunol. 2024; 15:1419660.

PMID: 39040109 PMC: 11260631. DOI: 10.3389/fimmu.2024.1419660.


Virus-Induced MicroRNA Modulation and Systemic Sclerosis Disease.

Soffritti I, DAccolti M, Bini F, Mazziga E, Di Luca D, Maccari C Biomedicines. 2024; 12(6).

PMID: 38927567 PMC: 11202132. DOI: 10.3390/biomedicines12061360.


Exosomes in Action: Unraveling Their Role in Autoimmune Diseases and Exploring Potential Therapeutic Applications.

Zhou S, Huang J, Zhang Y, Yu H, Wang X Immune Netw. 2024; 24(2):e12.

PMID: 38725675 PMC: 11076296. DOI: 10.4110/in.2024.24.e12.


References
1.
Pilson Q, Smith S, Jefferies C, Ni Gabhann-Dromgoole J, Murphy C . miR-744-5p contributes to ocular inflammation in patients with primary Sjogrens Syndrome. Sci Rep. 2020; 10(1):7484. PMC: 7198540. DOI: 10.1038/s41598-020-64422-5. View

2.
Volpe A, Biasi D, Caramaschi P, Mantovani W, Bambara L, Canestrini S . Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features. Rheumatology (Oxford). 2005; 45(3):314-20. DOI: 10.1093/rheumatology/kei151. View

3.
Zhang D, Deng J, Wu Y, Tang T, Xiong L, Zheng Y . MicroRNA-223-3p Protect Against Radiation-Induced Cardiac Toxicity by Alleviating Myocardial Oxidative Stress and Programmed Cell Death Targeting the AMPK Pathway. Front Cell Dev Biol. 2022; 9:801661. PMC: 8801819. DOI: 10.3389/fcell.2021.801661. View

4.
Zhou B, Wu L, Zheng F, Wu N, Chen A, Zhou H . miR-31-5p Promotes Oxidative Stress and Vascular Smooth Muscle Cell Migration in Spontaneously Hypertensive Rats via Inhibiting FNDC5 Expression. Biomedicines. 2021; 9(8). PMC: 8393189. DOI: 10.3390/biomedicines9081009. View

5.
Shimizu C, Kim J, Stepanowsky P, Trinh C, Lau H, Akers J . Differential expression of miR-145 in children with Kawasaki disease. PLoS One. 2013; 8(3):e58159. PMC: 3590129. DOI: 10.1371/journal.pone.0058159. View